Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study.
Migraine
adolescents
headache
life-style modification
preventive medication
Journal
Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
26
3
2022
medline:
9
9
2022
entrez:
25
3
2022
Statut:
ppublish
Résumé
Assessment of the prevalence of primary headache disorders, associated risk factors and use of acute/preventive medication in a representative large sample of adolescents. Within the EVA-Tyrol project, a community-based non-randomized controlled cross-sectional study, data was collected from adolescents aged 14-19 years from 45 sites across North-, East- and South Tyrol. Headaches were classified according to the latest ICHD-3 and assessed by headache specialists in face-to-face interviews. Of 1923 participants 930 (48.4%) reported having headaches. Female to male ratio was 2:1. Migraine, tension-type headache and other headache were diagnosed in 10%, 30.2% and 8.2% respectively. Medication overuse was diagnosed in 3.4%, increasing up to 21.7% in participants with chronic headache. The use of preventative medication was not reported by any adolescent. Sleep disturbances (p < 0.05), alcohol consumption (p < 0.05), low physical activity (p < 0.01) and high screen time exposure (p < 0.01) were associated with an increased risk of headaches. We report high prevalence of primary headache disorders and medication overuse in a large community-based sample of teenagers. Acute and preventive non-drug and pharmacological treatments are not established due to lack of paediatric headache outpatient clinics. Promoting health education in teenagers and encouraging public awareness, including that of health care providers is pivotal.
Identifiants
pubmed: 35331020
doi: 10.1177/03331024221088997
pmc: PMC9442274
doi:
Banques de données
ClinicalTrials.gov
['NCT03929692']
Types de publication
Controlled Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
993-1004Références
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Cephalalgia. 2016 Oct;36(11):1020-1027
pubmed: 26634831
Cephalalgia. 2004 May;24(5):373-9
pubmed: 15096226
Neurology. 2006 Jan 24;66(2):198-201
pubmed: 16434653
J Headache Pain. 2019 Apr 8;20(1):35
pubmed: 30961531
Neurology. 2019 Sep 10;93(11):487-499
pubmed: 31413171
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Lancet Neurol. 2006 Mar;5(3):268-74
pubmed: 16488382
Neurology. 2007 Feb 20;68(8):591-6
pubmed: 17182975
Soc Sci Med. 2008 Mar;66(6):1429-36
pubmed: 18179852
Headache. 2001 Jan;41(1):11-20
pubmed: 11168599
Eur J Pediatr. 2000 Aug;159(8):608-14
pubmed: 10968240
Dev Med Child Neurol. 2010 Dec;52(12):1088-97
pubmed: 20875042
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1286-1292
pubmed: 33558093
Cephalalgia. 2019 Jan;39(1):91-99
pubmed: 29771141
Pediatrics. 2015 Oct;136(4):819-22
pubmed: 26416932
Continuum (Minneap Minn). 2018 Aug;24(4, Headache):1108-1136
pubmed: 30074552
BMC Cardiovasc Disord. 2020 Feb 5;20(1):59
pubmed: 32024473
BMC Neurol. 2020 Jul 8;20(1):275
pubmed: 32640997
Scand J Med Sci Sports. 2018 Mar;28(3):1103-1112
pubmed: 29161767
J Headache Pain. 2018 May 18;19(1):34
pubmed: 29777424
Int J Environ Res Public Health. 2020 Dec 31;18(1):
pubmed: 33396281
J Headache Pain. 2019 Nov 6;20(1):101
pubmed: 31694547
Cephalalgia. 2003 Jul;23(6):420-8
pubmed: 12807521
Circulation. 2003 Sep 2;108(9):1064-9
pubmed: 12952827
Curr Pain Headache Rep. 2013 Jun;17(6):341
pubmed: 23700075
J Headache Pain. 2016;17:14
pubmed: 26910064
Stroke. 2009 Apr;40(4):1063-9
pubmed: 19211497
Am J Clin Nutr. 2018 Aug 1;108(2):371-380
pubmed: 29955838
Headache. 2012 Nov-Dec;52(10):1506-10
pubmed: 22822711
J Pediatr. 2020 Jul;222:120-126.e3
pubmed: 32423681
Neurology. 2010 Aug 24;75(8):712-7
pubmed: 20720191
J Adolesc Health. 2009 May;44(5):493-9
pubmed: 19380098
Curr Pain Headache Rep. 2014 Jul;18(7):428
pubmed: 24898106